Ionolyte

Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride and Sodium Acetate Trihydrate, the active ingredients in Ionolyte, is an electrolyte solution presented as an intravenous solution for intravenous use. It restores extracellular fluid volume and corrects electrolyte imbalances in patients with electrolyte depletion, hypovolemia or specific mineral deficiencies.

GNH USA supplies Ionolyte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ionolyte is an intravenous electrolyte solution used in conditions that involve fluid loss or mineral deficiency. - Electrolyte depletion: restores electrolyte balance and extracellular fluid volume. - Fluid resuscitation: provides rapid volume expansion in acute dehydration or shock. - Hypovolemia: corrects low circulating blood volume to maintain perfusion. - Magnesium deficiency: supplies magnesium ions to normalize serum levels. - Potassium deficiency: delivers potassium to prevent arrhythmias. - Sodium deficiency: replenishes sodium to support osmotic balance.

Ionolyte may be associated with adverse reactions following intravenous administration.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Transient hyperkalemia: temporary rise in serum potassium. - Transient hypermagnesemia: temporary increase in serum magnesium. - Mild hypertension: slight elevation of blood pressure during infusion. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Severe hyperkalemia: marked elevation of potassium that can cause cardiac arrhythmia. - Severe hypermagnesemia: high magnesium levels leading to muscle weakness or respiratory depression. - Anaphylactic reaction: rare severe allergic response requiring immediate medical attention. - Cardiac arrhythmia: abnormal heart rhythm linked to electrolyte imbalance.

Ionolyte should be administered with attention to patient‑specific factors and proper handling. - Renal impairment: monitor electrolyte levels closely and adjust infusion rate. - Cardiac disease: avoid rapid infusion if risk of hyperkalemia or arrhythmia exists. - Pregnancy: use only when the potential benefit justifies the potential risk to the fetus. - Concurrent diuretics: anticipate increased electrolyte loss and consider supplemental dosing. - Electrolyte monitoring: obtain baseline and periodic serum electrolyte measurements during therapy. - Store at ambient temperature: keep in the original container, protect from light and moisture.

Ionolyte can interact with other medications that affect electrolyte balance or renal function.

Major Interactions (Avoid): - Calcium gluconate: may precipitate insoluble salts when mixed. - Loop diuretics: increase renal loss of potassium and magnesium, heightening deficiency risk. - ACE inhibitors: raise the likelihood of hyperkalemia during therapy.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia that signals electrolyte disturbance. - NSAIDs: can impair renal handling of sodium and potassium. - Blood transfusions: may alter sodium balance and require electrolyte reassessment.